Immix Biopharma Stock Operating Margin

IMMX Stock  USD 1.80  0.02  1.10%   
Immix Biopharma fundamentals help investors to digest information that contributes to Immix Biopharma's financial success or failures. It also enables traders to predict the movement of Immix Stock. The fundamental analysis module provides a way to measure Immix Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immix Biopharma stock.
Last ReportedProjected for Next Year
Operating Profit Margin 0.08  0.07 
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Immix Biopharma Company Operating Margin Analysis

Immix Biopharma's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Current Immix Biopharma Operating Margin

    
  0.0734  
Most of Immix Biopharma's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immix Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Immix Operating Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for Immix Biopharma is extremely important. It helps to project a fair market value of Immix Stock properly, considering its historical fundamentals such as Operating Margin. Since Immix Biopharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Immix Biopharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Immix Biopharma's interrelated accounts and indicators.
0.960.96-0.97-0.950.670.69-0.761.0-0.961.00.980.96-0.960.98-0.94-0.42
0.960.99-0.99-0.960.720.74-0.820.96-0.990.960.921.0-0.990.92-0.92-0.6
0.960.99-0.99-0.940.640.66-0.870.97-0.990.960.911.0-0.990.91-0.92-0.55
-0.97-0.99-0.990.96-0.67-0.690.83-0.981.0-0.97-0.93-0.991.0-0.930.940.5
-0.95-0.96-0.940.96-0.8-0.830.67-0.930.97-0.95-0.96-0.960.97-0.960.960.58
0.670.720.64-0.67-0.80.99-0.220.62-0.660.670.750.71-0.660.75-0.67-0.8
0.690.740.66-0.69-0.830.99-0.250.64-0.690.690.770.73-0.690.77-0.7-0.8
-0.76-0.82-0.870.830.67-0.22-0.25-0.810.83-0.76-0.63-0.830.83-0.630.680.31
1.00.960.97-0.98-0.930.620.64-0.81-0.971.00.960.96-0.970.96-0.93-0.41
-0.96-0.99-0.991.00.97-0.66-0.690.83-0.97-0.96-0.93-0.991.0-0.930.950.53
1.00.960.96-0.97-0.950.670.69-0.761.0-0.960.980.96-0.960.98-0.94-0.42
0.980.920.91-0.93-0.960.750.77-0.630.96-0.930.980.92-0.931.0-0.95-0.44
0.961.01.0-0.99-0.960.710.73-0.830.96-0.990.960.92-0.990.92-0.92-0.6
-0.96-0.99-0.991.00.97-0.66-0.690.83-0.971.0-0.96-0.93-0.99-0.930.950.53
0.980.920.91-0.93-0.960.750.77-0.630.96-0.930.981.00.92-0.93-0.95-0.44
-0.94-0.92-0.920.940.96-0.67-0.70.68-0.930.95-0.94-0.95-0.920.95-0.950.46
-0.42-0.6-0.550.50.58-0.8-0.80.31-0.410.53-0.42-0.44-0.60.53-0.440.46
Click cells to compare fundamentals
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Did you try this?

Run Portfolio Holdings Now

   

Portfolio Holdings

Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
All  Next Launch Module

Immix Fundamentals

About Immix Biopharma Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Immix Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immix Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immix Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immix Stock Analysis

When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.